|
|
||||||||
Cardiovascular Disease and Diabetes Research, Monsanto Company, St. Louis, Missouri 63167
Lithium has been shown to increase glucose uptake in skeletal muscle and adipose tissues. The therapeutic effect of lithium on bipolar disease is thought to be mediated by its inhibitory effect on myo-inositol-1-monophosphatase (IMPase). We tested the hypothesis that the stimulatory effect of lithium on glucose uptake results from inhibition of IMPase and the resultant accumulation of inositol monophosphates (IP1) by comparing the effects of lithium and a selective IMPase inhibitor, L-690,488, on isolated rat adipocytes. Insulin produced a concentration-dependent stimulation of 2-deoxy-D-[14C]glucose (2-DG) transport (10 µU/ml caused half-maximal activation). Acute exposure to lithium stimulated basal glucose transport activity in a concentration-dependent manner, with a threefold stimulation at 30 mM lithium. Lithium also potentiated insulin-stimulated 2-DG transport. Lithium produced a concomitant increase in IP1 accumulation. In contrast, L-690,488 increased IP1 to levels comparable to those of lithium without stimulatory effects on 2-DG transport. These results demonstrate that stimulatory effects of lithium on glucose transport are not mediated by the inhibition of IMPase and subsequent accumulation of IP1 in rat adipocytes.
prodrug; inositol monophosphatase inhibitor; insulin; isolated adipocytes
This article has been cited by other articles:
![]() |
J. Yin, A. Zuberi, Z. Gao, D. Liu, Z. Liu, and J. Ye Shilianhua extract inhibits GSK-3{beta} and promotes glucose metabolism Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1275 - E1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Ring, K. W. Johnson, E. J. Henriksen, J. M. Nuss, D. Goff, T. R. Kinnick, S. T. Ma, J. W. Reeder, I. Samuels, T. Slabiak, et al. Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo Diabetes, March 1, 2003; 52(3): 588 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Nikoulina, T. P. Ciaraldi, S. Mudaliar, L. Carter, K. Johnson, and R. R. Henry Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle Diabetes, July 1, 2002; 51(7): 2190 - 2198. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Fisher, L. A. Nolte, K. Kawanaka, D.-H. Han, T. E. Jones, and J. O. Holloszy Glucose transport rate and glycogen synthase activity both limit skeletal muscle glycogen accumulation Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1214 - E1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-D. Chen, V. C. Yang, P. S. Alexander, P.-Y. Lin, and Y.-M. Song Effects of Selected Minerals on Leptin Secretion in Streptozotocin-Induced Hyperglycemic Mice Experimental Biology and Medicine, October 1, 2001; 226(9): 836 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Orena, A. J. Torchia, and R. S. Garofalo Inhibition of Glycogen-synthase Kinase 3 Stimulates Glycogen Synthase and Glucose Transport by Distinct Mechanisms in 3T3-L1 Adipocytes J. Biol. Chem., May 19, 2000; 275(21): 15765 - 15772. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |